MSB 2.03% $1.45 mesoblast limited

banter and General Discussion, page-9012

  1. 177 Posts.
    lightbulb Created with Sketch. 92
    reading the quarterly statements seems very promising, it is one of the toughest field to get drug approval. We have invested over two billion dollars in research and more than 15 years in development. If you want to multiply your money then it is right time to enter . We are very close to the success just little bit more patience. If Mesoblast was American company it would have orphan drug status or FDA approval already
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.